speb/financial-data huggingface dataset:
Financial ratios for HHS — quarterly report dated 2025-09-30
Total revenue: 39520000
Gross profit: 27796000
Operating income: 1047000
Net income: -2286000
Capital expenditures: 1006000
Operating cash flow: 3196000
Depreciation & amortization: 1218000
Net tangible assets: 19167000
Owner earnings: -2074000
Return on net tangible assets (%): -10.820681379454271
Capex to operating income (%): 96.08404966571156
Buffett classification: The Gruesome
Stock price: 3.71
Shares outstanding: 7419470
Book value: 19880000
P/B ratio: 1.3846194014084505
Market cap (USD): 27526233.7
Debt to equity: 1.0945674044265594
Current ratio: 1.4759653270291568
Quick ratio: 1.4759653270291568
Effective tax rate (%): 816.6144200626959
COGS to revenue (%): 29.66599190283401
SG&A to revenue (%): 64.60273279352226
Free cash flow (dilution-adjusted): 2040000
Buyback yield (%): 0.05812636837418117
Retained earnings: 811610000
Receivables turnover: 1.0283632578714546
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.7533870346490714
FCF margin (%): 5.161943319838056
Revenue growth (%): 2.3012606455955065
Rule of 40 score: 7.4632039654335625
Financial ratios for HHS — quarterly report dated 2025-12-31
Total revenue: 39858000
Gross profit: 28141000
Operating income: 140000
Net income: 2202000
Capital expenditures: 1422000
Operating cash flow: 737000
Depreciation & amortization: 1126000
Net tangible assets: 19861000
Owner earnings: 1906000
Return on net tangible assets (%): 9.59669704445899
Capex to operating income (%): 1015.7142857142857
Buffett classification: The Gruesome
Stock price: 3.01
P/E ratio: 2.5354909968210717
Shares outstanding: 7419470
Book value: 20526000
P/B ratio: 1.0880154292117314
Market cap (USD): 22332604.7
Debt to equity: 1.0914937152879276
Current ratio: 1.535505901074128
Quick ratio: 1.535505901074128
COGS to revenue (%): 29.39685884891364
SG&A to revenue (%): 67.42686537207085
Free cash flow (dilution-adjusted): -623000
Buyback yield (%): 0
Retained earnings: 813812000
Receivables turnover: 1.0973816800198233
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.2270442087509325
FCF margin (%): -1.563048823322796
Revenue growth (%): 0.855263157894737
Rule of 40 score: -0.707785665428059
Financial ratios for HHS — annual report dated 2025-12-31
Total revenue: 159570000
Gross profit: 109672000
Operating income: 2168000
Net income: -811000
Capital expenditures: 2756000
Operating cash flow: -1735000
Depreciation & amortization: 4472000
Net tangible assets: 19861000
Owner earnings: 905000
Capex to operating income (%): 127.12177121771218
Buffett classification: The Gruesome
Stock price: 3.01
Shares outstanding: 7419470
Book value: 20526000
P/B ratio: 1.0880154292117314
Market cap (USD): 22332604.7
Debt to equity: 1.0914937152879276
Current ratio: 1.535505901074128
Quick ratio: 1.535505901074128
COGS to revenue (%): 31.27028890142257
SG&A to revenue (%): 64.56852791878173
Free cash flow (dilution-adjusted): -4750000
Buyback yield (%): 0.2910542718736252
Retained earnings: 813812000
Receivables turnover: 4.393326174940118
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.5159417469430116
FCF margin (%): -2.9767500156671054
Revenue growth (%): -13.85862817287656
Rule of 40 score: -16.835378188543665
Financial ratios for HPF — annual report dated 2021-07-31
Total revenue: 14716099.48
Net income: 83710464
Capital expenditures: 0
Operating cash flow: 20439397
Net tangible assets: 439720363
Owner earnings: 83710464
Return on net tangible assets (%): 19.037204333427695
Buffett classification: The Gruesome
Stock price: 14.27
P/E ratio: 3.690785059201201
Shares outstanding: 21650829
Book value: 439720363
P/B ratio: 0.7026222932277529
Market cap (USD): 308957329.83
Debt to equity: 0.46393120984483494
COGS to revenue (%): 0
SG&A to revenue (%): 3.1249720798978995
Free cash flow (dilution-adjusted): 20439397
Buyback yield (%): 0
Retained earnings: -1779608
Receivables turnover: 1.8194889590061376
Capitalized R&D asset: 0
FCF margin (%): 138.8914027645592
Rule of 40 score: 138.8914027645592
Financial ratios for HPF — annual report dated 2022-07-31
Total revenue: -26299916
Net income: -26682617
Capital expenditures: 0
Operating cash flow: 28326630
Net tangible assets: 382104902
Owner earnings: -26682617
Return on net tangible assets (%): -6.983060636055384
Buffett classification: The Gruesome
Stock price: 13.14
Shares outstanding: 21650829
Book value: 382104902
P/B ratio: 0.744538715862902
Market cap (USD): 284491893.06
Debt to equity: 0.5409509245186287
Free cash flow (dilution-adjusted): 28326630
Buyback yield (%): 0
Retained earnings: -57386661
Receivables turnover: -5.1010804627218445
Capitalized R&D asset: 0
Revenue growth (%): -278.71526375411537
Rule of 40 score: -278.71526375411537
Financial ratios for HPF — annual report dated 2023-07-31
Total revenue: -24504048
Net income: -24961820
Capital expenditures: 0
Operating cash flow: 28105901
Net tangible assets: 326273736
Owner earnings: -24961820
Return on net tangible assets (%): -7.650575956870767
Buffett classification: The Gruesome
Stock price: 12.13
Shares outstanding: 21650829
Book value: 326273736
P/B ratio: 0.8049209200522349
Market cap (USD): 262624555.77
Debt to equity: 0.633517127471149
Free cash flow (dilution-adjusted): 28105901
Buyback yield (%): 0
Retained earnings: -108434079
Receivables turnover: -2.6458654653902385
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HPF — annual report dated 2024-07-31
Total revenue: 49987925
Net income: 49517618
Capital expenditures: 0
Operating cash flow: 33716008
Net tangible assets: 344883055
Owner earnings: 49517618
Return on net tangible assets (%): 14.357799631530172
Buffett classification: The Gruesome
Stock price: 14.24
P/E ratio: 6.226224471459835
Shares outstanding: 21650829
Book value: 344883055
P/B ratio: 0.8939488342215016
Market cap (USD): 308307804.96
Debt to equity: 0.5993335914981384
COGS to revenue (%): 0
SG&A to revenue (%): 0.6768774659080168
Free cash flow (dilution-adjusted): 33716008
Buyback yield (%): 0
Retained earnings: -84596734
Receivables turnover: 5.494723736048412
Capitalized R&D asset: 0
FCF margin (%): 67.4483047656009
Rule of 40 score: 67.4483047656009
Financial ratios for HPF — quarterly report dated 2025-01-31
Capital expenditures: 0
Net tangible assets: 348476921
Buffett classification: The Gruesome
Stock price: 14.8
Shares outstanding: 21650829
Book value: 348476921
P/B ratio: 0.919522211917156
Market cap (USD): 320432269.2
Debt to equity: 0.5931526237285596
Buyback yield (%): 0
Retained earnings: -81485287
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HPF — annual report dated 2025-07-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14.74
Shares outstanding: 21650829
Market cap (USD): 319133219.46
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HTLD — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.32
Shares outstanding: 77489696
Market cap (USD): 1264631838.72
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HTLD — annual report dated 2022-12-31
Total revenue: 967996000
Gross profit: 200690000
Operating income: 91452000
Net income: 133584000
Capital expenditures: 12182000
Operating cash flow: 194713000
Depreciation & amortization: 133047000
Net tangible assets: 462725000
Owner earnings: 254449000
Return on net tangible assets (%): 54.98924847371549
Capex to operating income (%): 13.32064908367231
Buffett classification: The Great
Stock price: 14.97
P/E ratio: 8.683830017966224
Shares outstanding: 77489696
Book value: 855477000
P/B ratio: 1.3559929128661554
Market cap (USD): 1160020749.1200001
Debt to equity: 0.5072748887462784
Current ratio: 1.4658484150628042
Quick ratio: 1.4658484150628042
Effective tax rate (%): 26.233771970998003
Interest coverage ratio: 10.68988895382817
COGS to revenue (%): 79.26747631188559
SG&A to revenue (%): 4.280079669750701
Free cash flow (dilution-adjusted): 32746000
Buyback yield (%): 0
Retained earnings: 1051641000
Receivables turnover: 6.771191538773626
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.0454899119539425
FCF margin (%): 3.3828652184513164
Rule of 40 score: 3.3828652184513164
Financial ratios for HTLD — annual report dated 2023-12-31
Total revenue: 1207458000
Gross profit: 145281000
Operating income: 1298000
Net income: 14775000
Capital expenditures: 71277000
Operating cash flow: 165267000
Depreciation & amortization: 199039000
Net tangible assets: 444126000
Owner earnings: 142537000
Return on net tangible assets (%): 32.0938202221892
Capex to operating income (%): 5491.294298921417
Buffett classification: The Gruesome
Stock price: 13.99
P/E ratio: 73.37264616175973
Shares outstanding: 77489696
Book value: 865260000
P/B ratio: 1.2528960625014445
Market cap (USD): 1084080847.04
Debt to equity: 0.3668735409010008
Current ratio: 1.3708898895331887
Quick ratio: 1.3708898895331887
Effective tax rate (%): 25.577998287412484
Interest coverage ratio: 0.0536651920453136
COGS to revenue (%): 87.96802870161943
SG&A to revenue (%): 4.620119291933963
Free cash flow (dilution-adjusted): -44949000
Buyback yield (%): 0
Retained earnings: 1060094000
Receivables turnover: 10.695217764865319
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.09363930830994756
FCF margin (%): -3.722613954274186
Revenue growth (%): 24.737912140132813
Rule of 40 score: 21.015298185858626
Financial ratios for HTLD — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.11
Shares outstanding: 77489696
Market cap (USD): 938400218.56
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HTLD — annual report dated 2024-12-31
Total revenue: 1047511000
Gross profit: 110159000
Operating income: -27744000
Net income: -29722000
Capital expenditures: 46543000
Operating cash flow: 144348000
Depreciation & amortization: 181523000
Net tangible assets: 406482000
Owner earnings: 105258000
Buffett classification: The Gruesome
Stock price: 11.08
Shares outstanding: 77489696
Book value: 822599000
P/B ratio: 1.0437477211618298
Market cap (USD): 858585831.68
Debt to equity: 0.25360351763131245
Current ratio: 1.082712301039654
Quick ratio: 1.082712301039654
Interest coverage ratio: -1.5779774769650778
COGS to revenue (%): 89.4837381182632
SG&A to revenue (%): 5.758030225935575
Free cash flow (dilution-adjusted): 33772000
Buyback yield (%): 0.848022379516003
Retained earnings: 1024081000
Receivables turnover: 11.18490400837124
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.284146734034066
FCF margin (%): 3.2240234231430507
Revenue growth (%): -13.246589115314983
Rule of 40 score: -10.022565692171932
Financial ratios for HTLD — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.08
Shares outstanding: 77489696
Market cap (USD): 858585831.68
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HTLD — quarterly report dated 2025-03-31
Total revenue: 219420000
Gross profit: 15084000
Operating income: -16682000
Net income: -13873000
Capital expenditures: 11653000
Operating cash flow: 25843000
Depreciation & amortization: 41628000
Net tangible assets: 392877000
Owner earnings: 16102000
Buffett classification: The Gruesome
Stock price: 9.13
Shares outstanding: 77489696
Book value: 807725000
P/B ratio: 0.8758933108174194
Market cap (USD): 707480924.48
Debt to equity: 0.2547389272338977
Current ratio: 0.9030038392036064
Quick ratio: 0.9030038392036064
Interest coverage ratio: -5.3726247987117555
COGS to revenue (%): 93.12551271534045
SG&A to revenue (%): 6.4661380001822995
Free cash flow (dilution-adjusted): 1618000
Buyback yield (%): 0
Retained earnings: 1008636000
Receivables turnover: 2.309903043446221
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.4027799968046013
FCF margin (%): 0.7373985962993346
Rule of 40 score: 0.7373985962993346
Financial ratios for HTLD — quarterly report dated 2025-06-30
Total revenue: 210387000
Gross profit: 17274000
Operating income: -15201000
Net income: -10855000
Capital expenditures: 5833000
Operating cash flow: 20999000
Depreciation & amortization: 41463000
Net tangible assets: 373153000
Owner earnings: 24775000
Buffett classification: The Gruesome
Stock price: 8.57
Shares outstanding: 77489696
Book value: 786737000
P/B ratio: 0.8441025332735081
Market cap (USD): 664086694.72
Debt to equity: 0.252248210011732
Current ratio: 0.9483230401815865
Quick ratio: 0.9483230401815865
Interest coverage ratio: -5.1320054017555705
COGS to revenue (%): 91.7894166464658
SG&A to revenue (%): 7.7761458645258505
Free cash flow (dilution-adjusted): -13258000
Buyback yield (%): 0
Retained earnings: 996229000
Receivables turnover: 2.396835161830548
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.3152509757741517
FCF margin (%): -6.301720163318075
Revenue growth (%): -4.116762373530216
Rule of 40 score: -10.418482536848291
Financial ratios for HTLD — quarterly report dated 2025-09-30
Total revenue: 196547000
Gross profit: 18801000
Operating income: -13940000
Net income: -8284000
Capital expenditures: 6881000
Operating cash flow: 27530000
Depreciation & amortization: 38742000
Net tangible assets: 363300000
Owner earnings: 23577000
Buffett classification: The Gruesome
Stock price: 8.33
Shares outstanding: 77489696
Book value: 775630000
P/B ratio: 0.8322127401982904
Market cap (USD): 645489167.68
Debt to equity: 0.2424480744684966
Current ratio: 1.1373989229426393
Quick ratio: 1.1373989229426393
Interest coverage ratio: -4.793672627235213
COGS to revenue (%): 90.43434903610842
SG&A to revenue (%): 8.918477514284115
Free cash flow (dilution-adjusted): -12373000
Buyback yield (%): 0.22138249122538706
Retained earnings: 986396000
Receivables turnover: 2.4338075956263854
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.2269225894579712
FCF margin (%): -6.295186393076466
Revenue growth (%): -6.578353225246807
Rule of 40 score: -12.873539618323273
Financial ratios for HTLD — annual report dated 2025-12-31
Total revenue: 805709000
Gross profit: 67544000
Operating income: -61867000
Net income: -52453000
Capital expenditures: 26251000
Operating cash flow: 89314000
Depreciation & amortization: 159198000
Net tangible assets: 363210000
Owner earnings: 80494000
Buffett classification: The Gruesome
Stock price: 9
Shares outstanding: 77489696
Book value: 755319000
P/B ratio: 0.9233281090506131
Market cap (USD): 697407264
Debt to equity: 0.21371102805569567
Current ratio: 1.040267237936168
Quick ratio: 1.040267237936168
Interest coverage ratio: -5.384421235857268
COGS to revenue (%): 91.61682443661421
SG&A to revenue (%): 8.247270416490322
Free cash flow (dilution-adjusted): -69010000
Buyback yield (%): 1.4905207525914155
Retained earnings: 965405000
Receivables turnover: 10.697429565309754
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.7207294260592
FCF margin (%): -8.565127111649492
Revenue growth (%): -23.08348074626424
Rule of 40 score: -31.64860785791373
Financial ratios for HTLD — quarterly report dated 2025-12-31
Total revenue: 179355000
Gross profit: 16385000
Operating income: -16044000
Net income: -19442000
Capital expenditures: 1884000
Operating cash flow: 14942000
Depreciation & amortization: 37365000
Net tangible assets: 363210000
Owner earnings: 16039000
Buffett classification: The Gruesome
Stock price: 9
Shares outstanding: 77489696
Book value: 755319000
P/B ratio: 0.9233281090506131
Market cap (USD): 697407264
Debt to equity: 0.21371102805569567
Current ratio: 1.040267237936168
Quick ratio: 1.040267237936168
Interest coverage ratio: -6.376788553259141
COGS to revenue (%): 90.86448663265591
SG&A to revenue (%): 10.243372083298487
Free cash flow (dilution-adjusted): -44997000
Buyback yield (%): 0.005018588392563688
Retained earnings: 965405000
Receivables turnover: 2.381303274117741
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.4835596184022792
FCF margin (%): -25.088232834322994
Revenue growth (%): -8.747017252870815
Rule of 40 score: -33.83525008719381
Financial ratios for IBAB.BR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.09090909090909
Shares outstanding: 29040213
Market cap (USD): 467283427.3636363
Buyback yield (%): 2.73023903660217
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IBAB.BR — annual report dated 2022-12-31
Total revenue: 384329787.2340426
Gross profit: 134856382.9787234
Operating income: 5278723.404255319
Net income: 6443617.021276596
Capital expenditures: 3437234.0425531915
Operating cash flow: 23097872.340425532
Depreciation & amortization: 11394680.85106383
Net tangible assets: 104373404.25531915
Owner earnings: 14401063.829787234
Return on net tangible assets (%): 13.797637369917744
Capex to operating income (%): 65.1148730350665
Buffett classification: The Good
Stock price: 15.574468085106384
P/E ratio: 70.19130234769688
Shares outstanding: 29040213
Book value: 123352127.65957451
P/B ratio: 3.6666239904787354
Market cap (USD): 452285870.5531915
Debt to equity: 0.352450604134505
Current ratio: 1.0852263363777506
Quick ratio: 0.8644995793326569
Interest coverage ratio: 2.4134241245136185
COGS to revenue (%): 64.91128518836327
R&D to revenue (%): 11.581088936252664
SG&A to revenue (%): 20.44897168322861
Free cash flow (dilution-adjusted): 15301063.829787236
Buyback yield (%): 1.2136929449981742
Retained earnings: 54713829.787234046
Inventory turnover: 2.303743872368434
Receivables turnover: 3.235765658447456
Capitalized R&D asset: 44509574.46808511
ROCI (R&D-adjusted, %): 16.06066827657903
FCF margin (%): 3.98123287292053
Rule of 40 score: 3.98123287292053
Financial ratios for IBAB.BR — annual report dated 2023-12-31
Total revenue: 518518888.8888889
Gross profit: 149378888.8888889
Operating income: 5938888.888888889
Net income: -10122222.222222222
Capital expenditures: 5850000
Operating cash flow: -21965555.555555556
Depreciation & amortization: 12801111.11111111
Net tangible assets: 92017777.77777778
Owner earnings: -3171111.111111112
Return on net tangible assets (%): -3.44619397217929
Capex to operating income (%): 98.50327408793265
Buffett classification: The Gruesome
Stock price: 12.222222222222221
Shares outstanding: 29040213
Book value: 118013333.33333337
P/B ratio: 3.0075918257823964
Market cap (USD): 354935936.6666666
Debt to equity: 0.39150943396226406
Current ratio: 0.9987715449148367
Quick ratio: 0.7103386868345408
Interest coverage ratio: 2.6200980392156863
COGS to revenue (%): 71.19123486340366
R&D to revenue (%): 10.269206950566463
SG&A to revenue (%): 17.164487739651612
Free cash flow (dilution-adjusted): -35647777.777777776
Buyback yield (%): 0
Retained earnings: 40056666.666666664
Inventory turnover: 2.544915546363323
Receivables turnover: 4.338021491782554
Capitalized R&D asset: 83069192.6713948
ROCI (R&D-adjusted, %): 10.897570898778987
Rosenberg metric: 0.32627824650578546
FCF margin (%): -6.874923660768813
Revenue growth (%): 34.9150927438081
Rule of 40 score: 28.040169083039288
Financial ratios for IBAB.BR — annual report dated 2024-12-31
Total revenue: 518913541.6666667
Gross profit: 175097916.6666667
Operating income: 10301041.666666668
Net income: 9638541.666666668
Capital expenditures: 4459375
Operating cash flow: -11030208.333333334
Depreciation & amortization: 12190625
Net tangible assets: 88806250
Owner earnings: 17369791.666666668
Return on net tangible assets (%): 19.5591995683487
Capex to operating income (%): 43.29052482556375
Buffett classification: The Good
Stock price: 13.500000000000002
P/E ratio: 40.67450129471523
Shares outstanding: 29040213
Book value: 115545833.33333337
P/B ratio: 3.392964196026107
Market cap (USD): 392042875.50000006
Debt to equity: 0.3939003281526089
Current ratio: 0.9546783282836143
Quick ratio: 0.6288381950648503
Effective tax rate (%): 37.88265306122449
Interest coverage ratio: 4.552946593001842
COGS to revenue (%): 66.25682264828157
R&D to revenue (%): 11.881595561238726
SG&A to revenue (%): 18.38376254875471
Free cash flow (dilution-adjusted): -18760416.666666668
Buyback yield (%): 0
Retained earnings: 41083333.333333336
Inventory turnover: 2.159815469179427
Receivables turnover: 6.110856231599607
Capitalized R&D asset: 112019379.01891254
ROCI (R&D-adjusted, %): 7.093611086625949
Rosenberg metric: 0.48300659391106593
FCF margin (%): -3.61532609197502
Revenue growth (%): 0.07611155277746486
Rule of 40 score: -3.5392145391975554
Financial ratios for IBAB.BR — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 88806250
Buffett classification: The Gruesome
Stock price: 13.500000000000002
Shares outstanding: 29040213
Book value: 115545833.33333337
P/B ratio: 3.392964196026107
Market cap (USD): 392042875.50000006
Debt to equity: 0.3939003281526089
Current ratio: 0.9546783282836143
Quick ratio: 0.6288381950648503
Buyback yield (%): 0
Retained earnings: 41083333.333333336
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IBAB.BR — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.23529411764706
Shares outstanding: 29040213
Market cap (USD): 384355760.2941177
Current ratio: 0.9359967386873217
Quick ratio: 0.6208935236328995
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IBM.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 111.0340909090909
Shares outstanding: 942134390
Market cap (USD): 104609035507.84091
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IBM.DE — annual report dated 2022-12-31
Total revenue: 60530000000
Gross profit: 32687000000
Operating income: 8174000000
Net income: 1640000000
Capital expenditures: 1235000000
Operating cash flow: 10435000000
Depreciation & amortization: 4802000000
Net tangible assets: -45189000000
Owner earnings: 5207000000
Return on net tangible assets (%): -11.522715705149484
Capex to operating income (%): 15.108881820406166
Buffett classification: The Great
Stock price: 122.4468085106383
P/E ratio: 70.34228612415673
Shares outstanding: 942134390
Book value: 22021000000
P/B ratio: 5.238697118369603
Market cap (USD): 115361349243.61703
Debt to equity: 2.452795059261614
Current ratio: 0.924234248531979
Quick ratio: 0.8749722266306935
Effective tax rate (%): -54.15224913494809
Interest coverage ratio: 6.722039473684211
COGS to revenue (%): 45.9970262679663
R&D to revenue (%): 10.849165702957212
SG&A to revenue (%): 30.743433008425576
Free cash flow (dilution-adjusted): 7476000000
Buyback yield (%): 0.35280447278794236
Retained earnings: 149825000000
Inventory turnover: 17.939432989690722
Receivables turnover: 4.259976071503976
Capitalized R&D asset: 6567000000
ROCI (R&D-adjusted, %): 12.26919505400518
FCF margin (%): 12.350900379976872
Rule of 40 score: 12.350900379976872
Financial ratios for IBM.DE — annual report dated 2023-12-31
Total revenue: 61860000000
Gross profit: 34300000000
Operating income: 9382000000
Net income: 7502000000
Capital expenditures: 924000000
Operating cash flow: 13931000000
Depreciation & amortization: 4396000000
Net tangible assets: -48681000000
Owner earnings: 10974000000
Return on net tangible assets (%): -22.54267578726813
Capex to operating income (%): 9.8486463440631
Buffett classification: The Great
Stock price: 151.56666666666666
P/E ratio: 19.034413362347816
Shares outstanding: 942134390
Book value: 22613000000
P/B ratio: 6.314782162664544
Market cap (USD): 142796169044.33334
Debt to equity: 2.6504665457922436
Current ratio: 0.9644217806693629
Quick ratio: 0.9303968114412988
Effective tax rate (%): 13.532796317606444
Interest coverage ratio: 5.838207840696951
COGS to revenue (%): 44.55221467830585
R&D to revenue (%): 10.952150016165534
SG&A to revenue (%): 30.719366311024892
Free cash flow (dilution-adjusted): 10988000000
Buyback yield (%): 0.2815201575016993
Retained earnings: 151276000000
Inventory turnover: 23.738156761412576
Receivables turnover: 4.43250214961307
Capitalized R&D asset: 11174890000
ROCI (R&D-adjusted, %): 10.42769706051386
Rosenberg metric: 0.24562204964215015
FCF margin (%): 17.76268994503718
Revenue growth (%): 2.1972575582355858
Rule of 40 score: 19.959947503272765
Financial ratios for IBM.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 208.98888888888888
Shares outstanding: 942134390
Market cap (USD): 196895619350.1111
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IBM.DE — annual report dated 2024-12-31
Total revenue: 62753000000
Gross profit: 35551000000
Operating income: 10074000000
Net income: 6023000000
Capital expenditures: 491000000
Operating cash flow: 13445000000
Depreciation & amortization: 4667000000
Net tangible assets: -44060000000
Owner earnings: 10199000000
Return on net tangible assets (%): -23.147980027235587
Capex to operating income (%): 4.873932896565416
Buffett classification: The Great
Stock price: 210.83333333333334
P/E ratio: 32.979135628701094
Shares outstanding: 942134390
Book value: 27393000000
P/B ratio: 7.251244255527569
Market cap (USD): 198633333891.6667
Debt to equity: 2.131785492644106
Current ratio: 1.0404320801400035
Quick ratio: 1.001538832900851
Effective tax rate (%): -3.7605658099016734
Interest coverage ratio: 5.884345794392523
COGS to revenue (%): 43.34613484614282
R&D to revenue (%): 11.918155307315985
SG&A to revenue (%): 28.540468184787976
Free cash flow (dilution-adjusted): 10449000000
Buyback yield (%): 0.3277395526951438
Retained earnings: 151163000000
Inventory turnover: 21.102404965089217
Receivables turnover: 4.479157744468237
Capitalized R&D asset: 14185360000
ROCI (R&D-adjusted, %): 8.97717297606452
Rosenberg metric: 0.18464944649446494
FCF margin (%): 16.6509967650949
Revenue growth (%): 1.4435822825735531
Rule of 40 score: 18.094579047668454
Financial ratios for IBM.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 210.83333333333334
Shares outstanding: 942134390
Market cap (USD): 198633333891.6667
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IBM.DE — quarterly report dated 2025-03-31
Total revenue: 14541000000
Gross profit: 8031000000
Operating income: 1765000000
Net income: 1055000000
Capital expenditures: 170000000
Operating cash flow: 4370000000
Depreciation & amortization: 1177000000
Net tangible assets: -51576000000
Owner earnings: 2062000000
Return on net tangible assets (%): -3.9979835582441448
Capex to operating income (%): 9.631728045325778
Buffett classification: The Great
Stock price: 240.45652173913044
P/E ratio: 53.683023324696066
Shares outstanding: 942134390
Book value: 26952000000
P/B ratio: 8.405400654133919
Market cap (USD): 226542358430.2174
Debt to equity: 2.4797788661323836
Current ratio: 1.0065515866233692
Quick ratio: 0.9657893237623199
Effective tax rate (%): 8.894645941278066
Interest coverage ratio: 3.879120879120879
COGS to revenue (%): 44.76996080049515
R&D to revenue (%): 13.410356921807304
SG&A to revenue (%): 29.303349150677395
Free cash flow (dilution-adjusted): 3574000000
Buyback yield (%): 0.12536286898747082
Retained earnings: 150703000000
Inventory turnover: 4.549266247379455
Receivables turnover: 1.2237838747685574
Capitalized R&D asset: 1950000000
ROCI (R&D-adjusted, %): 2.7241780803654754
FCF margin (%): 24.578777250532976
Rule of 40 score: 24.578777250532976
Financial ratios for IBM.DE — quarterly report dated 2025-06-30
Total revenue: 16977000000
Gross profit: 9977000000
Operating income: 3086000000
Net income: 2194000000
Capital expenditures: 173000000
Operating cash flow: 1701000000
Depreciation & amortization: 1265000000
Net tangible assets: -52251000000
Owner earnings: 3286000000
Return on net tangible assets (%): -6.288874854069778
Capex to operating income (%): 5.60596241088788
Buffett classification: The Great
Stock price: 285.1764705882353
P/E ratio: 82.6945399076639
Shares outstanding: 942134390
Book value: 27588000000
P/B ratio: 9.738819782514136
Market cap (USD): 268674560160
Debt to equity: 2.454654197477164
Current ratio: 0.9079414727243811
Quick ratio: 0.8747813179239782
Effective tax rate (%): 15.55641124374278
Interest coverage ratio: 6.050980392156863
COGS to revenue (%): 41.23814572657125
R&D to revenue (%): 12.352005654709313
SG&A to revenue (%): 27.51369499911645
Free cash flow (dilution-adjusted): 887000000
Buyback yield (%): 0.05694621772485123
Retained earnings: 151367000000
Inventory turnover: 5.596322941646683
Receivables turnover: 1.331842786538009
Capitalized R&D asset: 3403500000
ROCI (R&D-adjusted, %): 3.35543157203807
Rosenberg metric: 0.997948717948718
FCF margin (%): 5.22471579195382
Revenue growth (%): 16.752630493088507
Rule of 40 score: 21.977346285042326
Financial ratios for IBM.DE — quarterly report dated 2025-09-30
Total revenue: 16331000000
Gross profit: 9360000000
Operating income: 2792000000
Net income: 1744000000
Capital expenditures: 248000000
Operating cash flow: 3082000000
Depreciation & amortization: 1283000000
Net tangible assets: -51221000000
Owner earnings: 2779000000
Return on net tangible assets (%): -5.425509068546104
Capex to operating income (%): 8.882521489971348
Buffett classification: The Great
Stock price: 278.36470588235295
P/E ratio: 52.524927373122374
Shares outstanding: 942134390
Book value: 27990000000
P/B ratio: 9.369666394212219
Market cap (USD): 262256962374
Debt to equity: 2.378313683458378
Current ratio: 0.9316487394001479
Quick ratio: 0.8918957372944055
Effective tax rate (%): 28.230452674897123
Interest coverage ratio: 5.67479674796748
COGS to revenue (%): 42.6795664686792
R&D to revenue (%): 12.748760026942623
SG&A to revenue (%): 26.79566468679199
Free cash flow (dilution-adjusted): 2222000000
Buyback yield (%): 0.1578604420078663
Retained earnings: 151581000000
Inventory turnover: 4.989262705798139
Receivables turnover: 1.3767492834260664
Capitalized R&D asset: 4130490000
ROCI (R&D-adjusted, %): 2.4553234769427257
Rosenberg metric: -0.2942298521697663
FCF margin (%): 13.606025350560284
Revenue growth (%): -3.8051481416033455
Rule of 40 score: 9.800877208956939
Financial ratios for IBM.DE — quarterly report dated 2025-12-31
Total revenue: 19687000000
Gross profit: 11928000000
Operating income: 4849000000
Net income: 5600000000
Capital expenditures: 379000000
Operating cash flow: 4040000000
Depreciation & amortization: 1296000000
Net tangible assets: -46459000000
Owner earnings: 6517000000
Return on net tangible assets (%): -14.027422028024711
Capex to operating income (%): 7.816044545267066
Buffett classification: The Great
Stock price: 301.7647058823529
P/E ratio: 26.838752676295663
Shares outstanding: 942134390
Book value: 32741000000
P/B ratio: 8.683391072355763
Market cap (USD): 284302907100
Debt to equity: 1.9732750985003513
Current ratio: 0.9556624760722231
Quick ratio: 0.9241036784106783
Effective tax rate (%): -34.63673666425296
Interest coverage ratio: 10.144351464435147
COGS to revenue (%): 39.40671509117692
R&D to revenue (%): 11.108853558185604
SG&A to revenue (%): 24.54411540610555
Free cash flow (dilution-adjusted): 3057000000
Buyback yield (%): 0.05874016615006326
Retained earnings: 155648000000
Inventory turnover: 6.359016393442623
Receivables turnover: 1.1925732977950085
Capitalized R&D asset: 4273950000
ROCI (R&D-adjusted, %): 4.182271814475307
Rosenberg metric: 1.2334293948126802
FCF margin (%): 15.528013409864377
Revenue growth (%): 20.549874471863326
Rule of 40 score: 36.077887881727705
Financial ratios for IBM.DE — annual report dated 2025-12-31
Total revenue: 67536000000
Gross profit: 39297000000
Operating income: 12492000000
Net income: 10593000000
Capital expenditures: 970000000
Operating cash flow: 13193000000
Depreciation & amortization: 5021000000
Net tangible assets: -46459000000
Owner earnings: 14644000000
Return on net tangible assets (%): -31.520265180051226
Capex to operating income (%): 7.76496958053154
Buffett classification: The Great
Stock price: 301.7647058823529
P/E ratio: 26.838752676295663
Shares outstanding: 942134390
Book value: 32741000000
P/B ratio: 8.683391072355763
Market cap (USD): 284302907100
Debt to equity: 1.9732750985003513
Current ratio: 0.9556624760722231
Quick ratio: 0.9241036784106783
Effective tax rate (%): -2.343144848954299
Interest coverage ratio: 6.455813953488372
COGS to revenue (%): 41.81325515280739
R&D to revenue (%): 12.313432835820896
SG&A to revenue (%): 26.86122956645345
Free cash flow (dilution-adjusted): 9740000000
Buyback yield (%): 0.3580687972500862
Retained earnings: 155648000000
Inventory turnover: 23.14672131147541
Receivables turnover: 4.091107341894839
Capitalized R&D asset: 15562680000
ROCI (R&D-adjusted, %): 10.315409151668248
Rosenberg metric: 0.5008691001470785
FCF margin (%): 14.421937929400617
Revenue growth (%): 7.621946361130146
Rule of 40 score: 22.043884290530762
Financial ratios for ILT.AX — annual report dated 2023-06-30
Operating income: -1121394.701986755
Net income: -1121394.701986755
Capital expenditures: 75974.17218543046
Net tangible assets: 3406986.754966887
Owner earnings: -1197368.8741721855
Return on net tangible assets (%): -35.144512153638324
Buffett classification: The Gruesome
Stock price: 0.152317880794702
Shares outstanding: 79724380
Book value: 3406986.754966887
P/B ratio: 3.564278197315606
Market cap (USD): 12143448.609271523
Debt to equity: 0
Current ratio: 8.252783817512801
Quick ratio: 8.252783817512801
Free cash flow (dilution-adjusted): -157898.67549668875
Buyback yield (%): 0.2742164834701102
Retained earnings: -1334869.536423841
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -32.91456006842193
Rule of 40 score: 0
Financial ratios for ILT.AX — annual report dated 2024-06-30
Operating income: -457103.3333333333
Net income: -393270
Capital expenditures: 1999.3333333333333
Net tangible assets: 3036430
Owner earnings: -395269.3333333333
Return on net tangible assets (%): -13.01756777970621
Buffett classification: The Gruesome
Stock price: 0.19333333333333333
Shares outstanding: 79724380
Book value: 3036430
P/B ratio: 5.0761519723271515
Market cap (USD): 15413380.133333333
Debt to equity: 0
Current ratio: 5.346093979413814
Quick ratio: 5.346093979413814
Free cash flow (dilution-adjusted): -1500462.6666666667
Buyback yield (%): 1.6573349331785332
Retained earnings: -1737038.6666666667
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -15.053972373258508
Rule of 40 score: 0
Financial ratios for JEN.DE — annual report dated 2021-12-31
Total revenue: 853087500
Gross profit: 291935227.27272725
Operating income: 90204545.45454545
Net income: 95839772.72727273
Capital expenditures: 779545.4545454546
Operating cash flow: 111402272.72727273
Depreciation & amortization: 61567045.45454545
Net tangible assets: 16548863.636363637
Owner earnings: 156627272.72727272
Return on net tangible assets (%): 946.4533406578314
Capex to operating income (%): 0.8641975308641976
Buffett classification: The Great
Stock price: 39.65909090909091
P/E ratio: 23.68548611555745
Shares outstanding: 57238115
Book value: 887112500
P/B ratio: 2.5588768124110524
Market cap (USD): 2270011606.25
Debt to equity: 0.765685145498867
Current ratio: 1.3655180136874865
Quick ratio: 0.9424842429095733
Effective tax rate (%): 9.44825837656512
Interest coverage ratio: 13.318791946308725
COGS to revenue (%): 65.778981959913
R&D to revenue (%): 5.1798480652496215
SG&A to revenue (%): 19.069103270606636
Free cash flow (dilution-adjusted): 58944318.18181818
Buyback yield (%): 0
Inventory turnover: 2.466443237951582
Receivables turnover: 6.231361123561931
Capitalized R&D asset: 44188636.36363637
ROCI (R&D-adjusted, %): 7.961604296834834
FCF margin (%): 6.909527824732889
Rule of 40 score: 6.909527824732889
Financial ratios for JEN.DE — annual report dated 2022-12-31
Total revenue: 1043280851.0638299
Gross profit: 367769148.9361702
Operating income: 126568085.10638298
Net income: 60674468.08510639
Capital expenditures: 1468085.1063829788
Operating cash flow: 151815957.44680852
Depreciation & amortization: 72622340.42553192
Net tangible assets: 107775531.91489363
Owner earnings: 131828723.40425533
Return on net tangible assets (%): 122.31785922277389
Capex to operating income (%): 1.159917292853901
Buffett classification: The Great
Stock price: 25.840425531914896
P/E ratio: 24.376929784865165
Shares outstanding: 57238115
Book value: 897135106.3829789
P/B ratio: 1.6486449339920097
Market cap (USD): 1479057248.244681
Debt to equity: 0.6365178991755077
Current ratio: 1.7554467058051884
Quick ratio: 0.9344068963066117
Effective tax rate (%): 33.45665631448402
Interest coverage ratio: 12.389253358325522
COGS to revenue (%): 64.7487875809129
R&D to revenue (%): 5.568562350359545
SG&A to revenue (%): 17.644419609170743
Free cash flow (dilution-adjusted): 67507446.80851065
Buyback yield (%): 0
Inventory turnover: 2.4988331870717917
Receivables turnover: 7.067025056028364
Capitalized R&D asset: 87702131.04448743
ROCI (R&D-adjusted, %): 9.796795585238636
Rosenberg metric: 1.71614079781489
FCF margin (%): 6.470687805654013
Revenue growth (%): 22.294706119106174
Rule of 40 score: 28.765393924760186
Financial ratios for JEN.DE — annual report dated 2023-12-31
Total revenue: 1184497777.7777777
Gross profit: 411690000
Operating income: 157512222.2222222
Net income: 81624444.44444445
Capital expenditures: 23742222.22222222
Operating cash flow: 185545555.55555555
Depreciation & amortization: 78744444.44444445
Net tangible assets: 204533333.3333333
Owner earnings: 136626666.6666667
Return on net tangible assets (%): 66.79921773142114
Capex to operating income (%): 15.073257101741664
Buffett classification: The Great
Stock price: 30.32222222222222
P/E ratio: 21.26307694250088
Shares outstanding: 57238115
Book value: 1003680000
P/B ratio: 1.7292233008639317
Market cap (USD): 1735586842.611111
Debt to equity: 0.5432895832226295
Current ratio: 2.119436398632108
Quick ratio: 1.1227327939005476
Effective tax rate (%): 33.72659932659933
Interest coverage ratio: 8.618737840466926
COGS to revenue (%): 65.24349747853756
R&D to revenue (%): 5.714845860599148
SG&A to revenue (%): 15.850224380140482
Free cash flow (dilution-adjusted): 86593333.33333333
Buyback yield (%): 0
Inventory turnover: 2.6080665059265122
Receivables turnover: 7.390793122573489
Capitalized R&D asset: 121198621.15839243
ROCI (R&D-adjusted, %): 10.056246925686969
Rosenberg metric: 0.7560080571323932
FCF margin (%): 7.310552620519902
Revenue growth (%): 13.535849581629853
Rule of 40 score: 20.846402202149754
Financial ratios for JEN.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 29.8
Shares outstanding: 57238115
Market cap (USD): 1705695827
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JEN.DE — quarterly report dated 2024-12-31
Total revenue: 313198958.3333334
Gross profit: 100478125
Operating income: 40652083.333333336
Net income: 28559375
Capital expenditures: 61125000
Operating cash flow: 61364583.333333336
Depreciation & amortization: 19702083.333333336
Net tangible assets: 278713541.6666667
Owner earnings: -12863541.666666664
Return on net tangible assets (%): -4.615327116775362
Capex to operating income (%): 150.36129759647415
Buffett classification: The Gruesome
Stock price: 22.708333333333336
P/E ratio: 11.377894253565307
Shares outstanding: 57238115
Book value: 1007495833.3333333
P/B ratio: 1.2901117322652287
Market cap (USD): 1299782194.7916667
Debt to equity: 0.49743381899842437
Current ratio: 2.257210994682095
Quick ratio: 1.2406936664404546
Effective tax rate (%): 32.626597997437976
Interest coverage ratio: 79.32113821138212
COGS to revenue (%): 67.91875505120214
R&D to revenue (%): 5.9363889433966035
SG&A to revenue (%): 12.563898746470393
Free cash flow (dilution-adjusted): 31175000
Buyback yield (%): 0
Inventory turnover: 0.7702479962281943
Receivables turnover: 2.2983565204097234
Capitalized R&D asset: 18592708.333333336
ROCI (R&D-adjusted, %): 3.401732706942117
FCF margin (%): 9.953736808671271
Rule of 40 score: 9.953736808671271
Financial ratios for JEN.DE — annual report dated 2024-12-31
Total revenue: 1162278125
Gross profit: 388695833.3333334
Operating income: 149565625
Net income: 98169791.66666667
Capital expenditures: 3196875
Operating cash flow: 174083333.33333334
Depreciation & amortization: 78033333.33333334
Net tangible assets: 278713541.6666667
Owner earnings: 173006250
Return on net tangible assets (%): 62.073141105899495
Capex to operating income (%): 2.1374396690415995
Buffett classification: The Great
Stock price: 22.708333333333336
P/E ratio: 13.24014416985877
Shares outstanding: 57238115
Book value: 1007495833.3333333
P/B ratio: 1.2901117322652287
Market cap (USD): 1299782194.7916667
Debt to equity: 0.49743381899842437
Current ratio: 2.257210994682095
Quick ratio: 1.2406936664404546
Effective tax rate (%): 28.98730779554431
Interest coverage ratio: 56.842042755344416
COGS to revenue (%): 66.55741642446095
R&D to revenue (%): 5.737923098225737
SG&A to revenue (%): 14.842617811464015
Free cash flow (dilution-adjusted): 76166666.66666667
Buyback yield (%): 0
Inventory turnover: 2.8010900518623294
Receivables turnover: 8.52917749579575
Capitalized R&D asset: 131216009.63356975
ROCI (R&D-adjusted, %): 9.096470630165612
Rosenberg metric: -0.3396869819280069
FCF margin (%): 6.553222075539508
Revenue growth (%): -1.8758712084258782
Rule of 40 score: 4.6773508671136295
Financial ratios for JEN.DE — quarterly report dated 2025-03-31
Total revenue: 264768478.26086956
Gross profit: 81910869.56521739
Operating income: 18373913.04347826
Net income: 10080434.782608695
Capital expenditures: 293478.2608695652
Operating cash flow: 49043478.26086956
Depreciation & amortization: 21000000
Net tangible assets: 307414130.4347826
Owner earnings: 30786956.52173913
Return on net tangible assets (%): 10.014815024344019
Capex to operating income (%): 1.5972550875532416
Buffett classification: The Great
Stock price: 20.16304347826087
P/E ratio: 28.62214344538495
Shares outstanding: 57238115
Book value: 1056159782.6086955
P/B ratio: 1.092727275136441
Market cap (USD): 1154094601.3586957
Debt to equity: 0.4460715450869486
Current ratio: 1.5214703019827756
Quick ratio: 0.7669849976418244
Effective tax rate (%): 28.262228473198935
Interest coverage ratio: 2.4782289986805455
COGS to revenue (%): 69.0632094487801
R&D to revenue (%): 6.620221933025981
SG&A to revenue (%): 17.340826891418672
Free cash flow (dilution-adjusted): 20500000
Buyback yield (%): 0
Inventory turnover: 0.6078691391570792
Receivables turnover: 2.2049060873500794
Capitalized R&D asset: 29985375.45289855
ROCI (R&D-adjusted, %): 1.6320385955142531
Rosenberg metric: -0.9986310279226457
FCF margin (%): 7.742613522068091
Revenue growth (%): -15.463167671496503
Rule of 40 score: -7.720554149428412
Financial ratios for JEN.DE — quarterly report dated 2025-06-30
Total revenue: 299769411.7647059
Gross profit: 94361176.47058824
Operating income: 26741176.470588237
Net income: 18931764.70588235
Capital expenditures: 482352.9411764706
Operating cash flow: 22356470.588235296
Depreciation & amortization: 23358823.529411767
Net tangible assets: 328280000
Owner earnings: 41808235.294117644
Return on net tangible assets (%): 12.735541395795554
Capex to operating income (%): 1.803783545974483
Buffett classification: The Great
Stock price: 22.764705882352942
P/E ratio: 22.632850756857007
Shares outstanding: 57238115
Book value: 1135562352.9411764
P/B ratio: 1.1474568964534806
Market cap (USD): 1303008853.235294
Debt to equity: 0.4608310160915349
Current ratio: 1.6234134073315014
Quick ratio: 0.8103343520172661
Effective tax rate (%): 29.12208936438011
Interest coverage ratio: 2.3969208056522198
COGS to revenue (%): 68.522079716174
R&D to revenue (%): 5.8484168223418775
SG&A to revenue (%): 16.59510839704243
Free cash flow (dilution-adjusted): 7703529.4117647065
Buyback yield (%): 0
Inventory turnover: 0.6491029139496324
Receivables turnover: 2.427120839763007
Capitalized R&D asset: 35411293.23849105
ROCI (R&D-adjusted, %): 1.654210431914713
Rosenberg metric: 0.7102990421022684
FCF margin (%): 2.56981837019827
Revenue growth (%): 13.219448830819966
Rule of 40 score: 15.789267201018236
Financial ratios for JEN.DE — quarterly report dated 2025-09-30
Total revenue: 299777647.0588235
Gross profit: 99638823.52941176
Operating income: 39187058.823529415
Net income: 25525882.352941178
Capital expenditures: 16470.58823529412
Operating cash flow: 62160000
Depreciation & amortization: 23158823.529411767
Net tangible assets: 356416470.5882353
Owner earnings: 48668235.29411765
Return on net tangible assets (%): 13.654878298355527
Capex to operating income (%): 0.04203068239815065
Buffett classification: The Great
Stock price: 20.023529411764706
P/E ratio: 13.792348439296918
Shares outstanding: 57238115
Book value: 1153995294.1176472
P/B ratio: 0.9931661636911556
Market cap (USD): 1146109079.1764705
Debt to equity: 0.42778133461651385
Current ratio: 1.5585917743344522
Quick ratio: 0.7813347740125981
Effective tax rate (%): 27.744298318628264
Interest coverage ratio: 9.411980785532636
COGS to revenue (%): 66.76242391419522
R&D to revenue (%): 5.652817186071245
SG&A to revenue (%): 15.279560144577745
Free cash flow (dilution-adjusted): 42105882.35294118
Buyback yield (%): 0
Inventory turnover: 0.6289648134933985
Receivables turnover: 2.333241765788534
Capitalized R&D asset: 34476490.79283888
ROCI (R&D-adjusted, %): 2.4580450220425583
Rosenberg metric: 0.3010334183331095
FCF margin (%): 14.0457044633081
Revenue growth (%): 0.002747209619937324
Rule of 40 score: 14.048451672928037
Financial ratios for JEN.DE — annual report dated 2025-12-31
Total revenue: 1230556470.5882354
Gross profit: 395608235.2941176
Operating income: 131135294.11764707
Net income: 87334117.64705883
Capital expenditures: 1294117.6470588236
Operating cash flow: 230632941.1764706
Depreciation & amortization: 90814117.64705883
Net tangible assets: 391177647.0588235
Owner earnings: 176854117.64705884
Return on net tangible assets (%): 45.21069109566589
Capex to operating income (%): 0.9868568608980397
Buffett classification: The Great
Stock price: 22.811764705882354
P/E ratio: 14.950656705148583
Shares outstanding: 57238115
Book value: 1187716470.5882354
P/B ratio: 1.0993384733829326
Market cap (USD): 1305702411.5882354
Debt to equity: 0.39740520365823095
Current ratio: 1.599921436555686
Quick ratio: 0.9260983718303838
Effective tax rate (%): 28.79718963929701
Interest coverage ratio: 43.036679536679536
COGS to revenue (%): 67.85127340763097
R&D to revenue (%): 5.914971036537271
SG&A to revenue (%): 15.83281786432346
Free cash flow (dilution-adjusted): 142551764.70588237
Buyback yield (%): 0
Inventory turnover: 3.042175156136809
Receivables turnover: 8.151285847880299
Capitalized R&D asset: 139808210.90686274
ROCI (R&D-adjusted, %): 7.910504126078921
Rosenberg metric: 0.1036487806312245
FCF margin (%): 11.584333438817255
Revenue growth (%): 5.874527285647347
Rule of 40 score: 17.458860724464603
Financial ratios for JEN.DE — quarterly report dated 2025-12-31
Total revenue: 344436470.5882353
Gross profit: 112951764.70588236
Operating income: 45320000
Net income: 32075294.11764706
Capital expenditures: 477647.0588235294
Operating cash flow: 93034117.64705883
Depreciation & amortization: 21567058.82352941
Net tangible assets: 391177647.0588235
Owner earnings: 53164705.88235295
Return on net tangible assets (%): 13.590936568611825
Capex to operating income (%): 1.053943201287576
Buffett classification: The Great
Stock price: 22.811764705882354
P/E ratio: 15.075066606399428
Shares outstanding: 57238115
Book value: 1187716470.5882354
P/B ratio: 1.0993384733829326
Market cap (USD): 1305702411.5882354
Debt to equity: 0.39740520365823095
Current ratio: 1.599921436555686
Quick ratio: 0.9260983718303838
Effective tax rate (%): 29.646972168148572
COGS to revenue (%): 67.20679302253296
R&D to revenue (%): 5.613944004016791
SG&A to revenue (%): 14.396576163622763
Free cash flow (dilution-adjusted): 70554117.64705883
Buyback yield (%): 0
Inventory turnover: 0.843425965219106
Receivables turnover: 2.2815695137157106
Capitalized R&D asset: 36475694.11764706
ROCI (R&D-adjusted, %): 2.917054958043131
Rosenberg metric: 0.7856151069147461
FCF margin (%): 20.483927711419504
Revenue growth (%): 14.897316049935059
Rule of 40 score: 35.38124376135456